Cosmos Health Inc. (COSM)
(Real Time Quote from BATS)
$0.90 USD
-0.03 (-3.42%)
Updated Sep 19, 2025 12:56 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
COSM 0.90 -0.03(-3.42%)
Will COSM be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for COSM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for COSM
Fast-paced Momentum Stock Cosmos Health Inc. (COSM) Is Still Trading at a Bargain
Ocular Therapeutix (OCUL) Reports Q3 Loss, Lags Revenue Estimates
COSM: What are Zacks experts saying now?
Zacks Private Portfolio Services
4D Molecular Therapeutics, Inc. (FDMT) Reports Q3 Loss, Lags Revenue Estimates
Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates
Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates
Other News for COSM
COSM forms Calm After Storm on September 18
COSM forms NR7 on September 17
COSM forms 180 Bullish Setup on September 16
COSM's price falls by 3.79% on September 15, though its technical setup remains stable.
COSM forms MACD Bullish Centerline Cross on September 12